Clinical Trials Festival Asia 2026: (Non-APAC Biopharma)

Clinical Trials Festival Asia 2026 is the region’s premier platform for accelerating clinical research and development, bringing together global and regional stakeholders to share insights, form strategic partnerships, and advance innovation in trial design and execution to deliver faster, smarter, and more inclusive trials across APAC.

Now in its fourth edition, CTFA 2026 presents a bold, future-focused agenda that tackles the most urgent challenges and opportunities across the entire clinical development spectrum. The 2026 edition highlights real-world strategies and innovations advancing the design, conduct, and delivery of trials. With a renewed focus on end-to-end integration, CTFA2026 highlights the evolving complexities and opportunities in APAC, covering everything from pre-clinical discovery and biomarker development to decentralised models, patient engagement, and trial monitoring technologies.

‍